Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Xerostomia 1Sexuality 1Sexual Dysfunction, Physiological 1Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Radiotherapy 5Radiation 4Low-Level Light Therapy 4Amifostine 3Acupuncture Therapy 3Surveys and Questionnaires 2Surgical Procedures, Operative 2Standard of Care 2Saliva, Artificial 2Oral Hygiene 2Iodine-131 2Cisplatin 2Chewing Gum 2pegfilgrastim 1ginger extract 1citric acid, deuterium oxide solution 1Xylitol 1Transcutaneous Electric Nerve Stimulation 1Smell 1Selenomethionine 1Respiration 1Pilocarpine 1Paclitaxel 1Mouthwashes 1Lansoprazole 1Health Education, Dental 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Filgrastim 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Xerostomia × Pilocarpine × Clear all
NCT00168181 2011-04-18

Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients

AHS Cancer Control Alberta

Phase 3 Completed
220 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Xerostomia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡